137 related articles for article (PubMed ID: 11172402)
1. Expanding the use of transjugular intrahepatic portosystemic shunts for veno-occlusive disease.
Rajvanshi P; McDonald GB
Liver Transpl; 2001 Feb; 7(2):154-7. PubMed ID: 11172402
[No Abstract] [Full Text] [Related]
2. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation.
Azoulay D; Castaing D; Lemoine A; Hargreaves GM; Bismuth H
Bone Marrow Transplant; 2000 May; 25(9):987-92. PubMed ID: 10800068
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.
Azoulay D; Castaing D; Lemoine A; Samuel D; Majno P; Reynes M; Charpentier B; Bismuth H
Clin Nephrol; 1998 Aug; 50(2):118-22. PubMed ID: 9725784
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of severe hepatic veno-occlusive disease after allogeneic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS).
Lévy V; Azoulay D; Rio B; Vincent F; Rabbat A; Hunault M; Bazarbachi A; Delmer A; Zittoun R
Bone Marrow Transplant; 1996 Aug; 18(2):443-45. PubMed ID: 8864460
[TBL] [Abstract][Full Text] [Related]
5. Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS).
Zenz T; Rössle M; Bertz H; Siegerstetter V; Ochs A; Finke J
Liver; 2001 Feb; 21(1):31-6. PubMed ID: 11169070
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of hepatic veno-occlusive disease in a peripheral blood progenitor cell transplant patient with a transjugular intrahepatic portosystemic stent-shunt (TIPS).
de la Rubia J; Carral A; Montes H; Urquijo JJ; Sanz GF; Sanz MA
Haematologica; 1996; 81(6):536-9. PubMed ID: 9009442
[TBL] [Abstract][Full Text] [Related]
7. TIPS for veno-occlusive disease: is the contraindication real?
Senzolo M; Cholongitas E; Patch D; Burroughs AK
Hepatology; 2005 Jul; 42(1):240-1; author reply 241. PubMed ID: 15962296
[No Abstract] [Full Text] [Related]
8. Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt.
Senzolo M; Patch D; Cholongitas E; Triantos C; Marelli L; Stigliano R; Dhillon A; Burroughs A
Transplantation; 2006 Jul; 82(1):132-5. PubMed ID: 16861953
[TBL] [Abstract][Full Text] [Related]
9. TIPS for veno-occlusive disease following stem cell transplantation.
Schoppmeyer K; Lange T; Wittekind C; Niederwieser D; Caca K
Z Gastroenterol; 2006 Jun; 44(6):483-6. PubMed ID: 16773513
[TBL] [Abstract][Full Text] [Related]
10. Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease.
Smith FO; Johnson MS; Scherer LR; Faught P; Breitfeld PP; Albright E; Hillier SC; Gowan D; Smith PD; Robertson KA; Emanuel D
Bone Marrow Transplant; 1996 Sep; 18(3):643-6. PubMed ID: 8879632
[TBL] [Abstract][Full Text] [Related]
11. [Percutaneous intrahepatic portosystemic shunting in the treatment of veno-occlusive disease of the liver after bone marrow transplantation].
Alvarez R; Bañares R; Casariego J; Echenagusía A; Simó G; Alvarez E; Serrano D; Díez-Martín JL
Gastroenterol Hepatol; 2000 Apr; 23(4):177-80. PubMed ID: 10863859
[TBL] [Abstract][Full Text] [Related]
12. Acute respiratory distress syndrome precipitated by transjugular intrahepatic porto-systemic shunting for severe hepatic veno-occlusive disease. Is it due to pulmonary leucostasis?
Meacher R; Venkatesh B; Lipman J
Intensive Care Med; 1999 Nov; 25(11):1332-3. PubMed ID: 10654223
[No Abstract] [Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature.
Campos-Varela I; Castells L; Dopazo C; Pérez-Lafuente M; Allende H; Len O; Llopart L; Vargas V; Charco R
Liver Transpl; 2012 Feb; 18(2):201-5. PubMed ID: 21656652
[TBL] [Abstract][Full Text] [Related]
14. Current role of portosystemic shunt surgery in the management of hepatic venous outflow obstruction.
Singhal D; de Castro S; Goyal N; Gouma DJ; Chaudhary A; van Gulik TM
Dig Surg; 2006; 23(5-6):358-69. PubMed ID: 17164547
[TBL] [Abstract][Full Text] [Related]
15. Miscellaneous indications for transjugular intrahepatic portosystemic stent-shunt.
Therapondos G; Wong F
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1161-6. PubMed ID: 17033435
[TBL] [Abstract][Full Text] [Related]
16. [Veno-occlusive disease of the liver and POEMS syndrome].
Andrès E; Kaltenbach G; Goichot B; Lioure B; Greget M; Schlienger JL; Imler M
Presse Med; 1999 Feb; 28(7):334-6. PubMed ID: 10083875
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of hepatic venoocclusive disease in a bone marrow transplant patient with orthotopic liver transplantation.
Nimer SD; Milewicz AL; Champlin RE; Busuttil RW
Transplantation; 1990 Apr; 49(4):819-21. PubMed ID: 2326879
[No Abstract] [Full Text] [Related]
18. Transjugular intrahepatic portosystemic shunt improves liver function in veno-occlusive disease.
Michielsen PP; Pelckmans PA; d'Archambeau OC; De Schepper AM; Van Marck EA; Meerman L; Haagsma EB; Jorens PG; Van Maercke YM
J Hepatol; 1994 Oct; 21(4):685-6. PubMed ID: 7814818
[No Abstract] [Full Text] [Related]
19. Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation.
Dowlati A; Honore P; Damas P; Deprez M; Delwaide J; Fillet G; Beguin Y
Transplantation; 1995 Jul; 60(1):106-9. PubMed ID: 7624933
[No Abstract] [Full Text] [Related]
20. No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation.
Hägglund H; Ringdén O; Ljungman P; Winiarski J; Ericzon B; Tydén G
Transplant Proc; 1995 Dec; 27(6):3535. PubMed ID: 8540088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
